APA (7th ed.) Citation

Ianotto, J., Ngo Sack, F., Couturier, M., Tempescul, A., Mugnier, N., Delepine, P., . . . Berthou, C. (2014). Biosimilars of filgrastim in autologous stem cell transplant: Reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery. Leukemia & Lymphoma, 55(1), 74. https://doi.org/10.3109/10428194.2013.791984

Chicago Style (17th ed.) Citation

Ianotto, Jean-Christophe, Françoise Ngo Sack, Marie-Anne Couturier, Adrian Tempescul, Nathalie Mugnier, Pascal Delepine, Gaelle Guillerm, and Christian Berthou. "Biosimilars of Filgrastim in Autologous Stem Cell Transplant: Reduction in Granulocyte-colony Stimulating Factor Costs, but Similar Effects on Bone Marrow Recovery." Leukemia & Lymphoma 55, no. 1 (2014): 74. https://doi.org/10.3109/10428194.2013.791984.

MLA (9th ed.) Citation

Ianotto, Jean-Christophe, et al. "Biosimilars of Filgrastim in Autologous Stem Cell Transplant: Reduction in Granulocyte-colony Stimulating Factor Costs, but Similar Effects on Bone Marrow Recovery." Leukemia & Lymphoma, vol. 55, no. 1, 2014, p. 74, https://doi.org/10.3109/10428194.2013.791984.